Why is Titan Biotech falling/rising?

As of 29-Aug, Titan Biotech Ltd's stock price is rising, currently at 723.50, reflecting an increase of 85.25 or 13.36%. The stock has shown impressive performance today, outperforming its sector by 13.81% and gaining for the last four consecutive days, resulting in a remarkable 62.24% return over the past week. It opened with a gain of 4.82% and reached an intraday high of Rs 749.7, indicating strong investor interest. The stock is trading above all key moving averages, and there has been a significant increase in delivery volume, suggesting rising investor participation. However, it is important to note that despite these positive indicators, the company has reported poor long-term growth, with operating profit declining at an annual rate of -3.08% over the last five years, and a low return on capital employed (ROCE) of 16.12%.
In the broader market context, Titan Biotech's short-term performance has significantly outpaced the benchmark, with a 62.24% return over the past week compared to a decline of 1.84% in the Sensex. While the stock has generated a 24.03% return over the past year, it has faced challenges with falling profits of -12.3%, which may contribute to concerns about its valuation, as it trades at a premium compared to its peers. Additionally, the lack of investment from domestic mutual funds, holding only 0% of the company, may indicate a lack of confidence in the stock's price sustainability or business fundamentals.